56 material Form 8-K filings that 54 companies we cover made with the SEC in November 2023, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
REX American Resources reported results for the fiscal 2023 third quarter ended October 31, 2023. Net income attributable to REX common shareholders rose to $26.1 million from $3.2 million a year earlier, and earnings per share were $1.49 versus $0.18, which the company described as an all-time quarterly record. For shareholders, the gain came mainly from lower corn and natural gas costs, with net sales and revenue nearly flat at $221.1 million.
Net income attributable to REX common shareholders was $26.1 million, compared with $3.2 million in Q3 2022.
Basic and diluted net income per share was $1.49, compared with $0.18 a year earlier, described as an all-time quarterly record.
Net sales and revenue were $221.1 million, compared with $220.3 million, as ethanol gallons sold rose to 73.2 million from 66.3 million.
Cash and short-term investments were $332.0 million at October 31, 2023, up from $280.9 million at January 31, 2023.
Pure Storage reported third quarter fiscal 2024 results for the quarter ended November 5, 2023, with revenue of $762.8 million, up 13% year-over-year, and GAAP net income of $70.4 million, compared with a net loss of $0.8 million a year earlier. The company gave fourth-quarter revenue guidance of $782 million and fiscal 2024 revenue guidance of $2.82 billion, and its release describes the annual non-GAAP operating margin guidance of 16% as increased. For shareholders, the filing shows higher sales and a return to GAAP profit, though the filing does not state the prior guidance figures for comparison.
Revenue $762.8 million, up 13% year-over-year; subscription services revenue $309.6 million, up 26%.
GAAP net income $70.4 million, or $0.21 per diluted share, versus a net loss of $0.8 million in the third quarter of fiscal 2023.
Non-GAAP operating margin 22.2% versus GAAP operating margin 9.7% for the quarter.
Life360 reported unaudited third-quarter 2023 results with total revenue of $78.6 million, up 38% from a year earlier, and a net loss of $6.5 million, narrowed from $21.1 million. It raised its calendar 2023 Adjusted EBITDA guidance to $12 million to $16 million from $9 million to $14 million and raised hardware revenue growth guidance to 10% to 15%, while reiterating consolidated revenue of $300 million to $310 million.
Q3 2023 total revenue of $78.6 million, up 38% year over year; core Life360 subscription revenue of $50.6 million, up 50%
Q3 2023 net loss of $6.5 million, compared with $21.1 million in Q3 2022; Adjusted EBITDA of $5.5 million, versus a loss of $9.4 million a year earlier
CY23 Adjusted EBITDA guidance raised to $12 million to $16 million; consolidated revenue guidance of $300 million to $310 million reiterated
Company expects fewer net subscriber additions in Q4 2023 than in Q3 2023, citing likely pull-forward effects in Q3 and seasonality
Arlo Technologies reported third-quarter 2023 revenue of $130.0 million, up 1.4% from a year earlier, with GAAP net loss per share narrowing to $(0.01) from $(0.16) and non-GAAP earnings per diluted share of $0.09 versus a $(0.05) loss a year earlier. Service revenue grew 44.0% to $51.0 million, and annual recurring revenue reached $200.0 million, which management highlighted as a key driver of profit improvement. The company also guided fourth-quarter revenue to $129 million to $139 million and non-GAAP EPS to $0.06 to $0.12.
Q3 revenue of $130.0 million, up 1.4% year over year; service revenue of $51.0 million, up 44.0%
GAAP net loss per share of $(0.01) vs. $(0.16) a year earlier; non-GAAP EPS of $0.09 vs. $(0.05)
Annual recurring revenue of $200.0 million, up 59.5% year over year; 2.5 million cumulative paid accounts
Q4 2023 outlook: revenue $129 million to $139 million; GAAP EPS $(0.05) to $0.01; non-GAAP EPS $0.06 to $0.12
Doximity reported fiscal second-quarter 2024 results for the period ended September 30, 2023, with revenue up 11% and net income up from the prior-year quarter. The company updated its fiscal 2024 revenue and adjusted EBITDA guidance and authorized a new $70 million share repurchase program, while operating cash flow fell 67% year-over-year.
Revenue of $113.6 million, up 11% from $102.2 million; net income of $30.6 million versus $26.3 million
Diluted net income per share of $0.15 versus $0.12; adjusted EBITDA of $54.2 million, up 18%
Operating cash flow of $12.9 million, down 67% from $39.5 million; restructuring expense of $7.9 million included in net income
Fiscal 2024 revenue guidance updated to $460 million to $472 million; board authorized up to $70 million in buybacks over the next 12 months
Veeco reported third-quarter 2023 revenue of $177.4 million, up from $171.9 million a year earlier, and GAAP net income of $24.6 million ($0.42 per diluted share), up from $15.0 million ($0.27). Its conference presentation raised the 2023 non-GAAP EPS outlook to $1.55 to $1.65 from $1.30 to $1.50, and the fourth-quarter revenue guidance is $155 million to $175 million.
Q3 2023 revenue $177.4 million vs $171.9 million in Q3 2022
GAAP diluted EPS $0.42 vs $0.27; non-GAAP diluted EPS $0.53 vs $0.45
Q4 2023 guidance: revenue $155 million to $175 million; non-GAAP diluted EPS $0.35 to $0.45
2023 non-GAAP EPS outlook raised to $1.55 to $1.65 from $1.30 to $1.50; nine-month GAAP net loss of $52.0 million reflects a $97 million loss on debt extinguishment
Krystal Biotech reported third quarter 2023 results, with net income of $80.7 million, or $2.88 per basic share, compared with a net loss of $29.9 million a year earlier. The result was driven by a $100 million gain from the sale of a Priority Review Voucher, while the company's loss from operations was $26.0 million and its first VYJUVEK product revenue was $8.6 million. Cash, cash equivalents and investments totaled $598.6 million at September 30, 2023.
Q3 2023 net income was $80.7 million, including a $100 million gain from the sale of a Priority Review Voucher.
Q3 2023 product revenues, net were $8.6 million, with 284 VYJUVEK Patient Start Forms received as of the end of the quarter.
Nine-month 2023 net income was $2.2 million, compared with a net loss of $107.9 million for the same period in 2022.
Saul Centers reported third-quarter 2023 results that improved on a year earlier. Total revenue rose to $63.8 million from $61.1 million, and net income available to common stockholders rose to $10.0 million, or $0.42 per share, from $9.2 million, or $0.38 per share. The filing gives no guidance, and the results were released in a press release furnished as Exhibit 99.1.
Total revenue for the quarter ended September 30, 2023 was $63.8 million, up from $61.1 million a year earlier.
Net income available to common stockholders was $10.0 million, or $0.42 per basic and diluted share, versus $9.2 million, or $0.38, in the 2022 quarter.
Diluted FFO per share available to common stockholders and noncontrolling interests was $0.76, up from $0.73.
As of September 30, 2023, 94.2% of the commercial portfolio was leased, compared with 93.0% a year earlier.
Penumbra reported third-quarter 2023 results, with revenue up 26.8% from a year earlier and GAAP net income of $9.2 million, compared with a net loss of $2.3 million in the third quarter of 2022. The company also said it expects fourth-quarter revenue growth of 28% to 31% and cited full-year 2023 revenue guidance of $1.05 billion to $1.07 billion.
Q3 2023 revenue was $270.9 million, up 26.8% (25.9% in constant currency) from $213.7 million in Q3 2022.
GAAP income from operations was $12.6 million, including a one-time $18.2 million acquired in-process R&D expense; non-GAAP income from operations was $33.2 million.
Thrombectomy product revenue rose 38.0% to $179.1 million, a company record.
Full-year 2023 revenue guidance is $1.05 billion to $1.07 billion, with fourth-quarter growth expected at 28% to 31%.
Qualys reported third-quarter 2023 revenue of $142.0 million, up 13% from a year earlier, and GAAP net income of $46.5 million, or $1.24 per diluted share, versus $0.71 a year earlier. The company raised its full-year 2023 GAAP EPS guidance to $3.71-$3.81 from $3.07-$3.22, which is a positive signal for shareholders, though the filing notes that about $0.29 of the quarter's EPS came from a change in tax estimates.
Q3 2023 revenue was $142.0 million, up 13% from $125.6 million in Q3 2022.
GAAP net income was $46.5 million, or $1.24 per diluted share, versus $0.71 a year earlier; about $0.29 per share reflected a tax estimate change.
Full-year 2023 GAAP EPS guidance was raised to $3.71-$3.81 from $3.07-$3.22; non-GAAP EPS guidance rose to $5.04-$5.14 from $4.50-$4.65.
Q3 operating cash flow was $92.4 million, up 119% from $42.2 million.
International Bancshares reported net income of $305.4 million, or $4.91 per diluted share, for the nine months ended September 30, 2023, up from $194.8 million, or $3.09 per diluted share, a year earlier. Third-quarter net income rose 23.9% to $103.3 million, or $1.66 per diluted share, with the company citing higher net interest income tied to rising interest rates and its investment portfolio.
Nine-month net income of $305.4 million, up 56.8% from $194.8 million in 2022
Nine-month diluted EPS of $4.91, up 58.9% from $3.09
Third-quarter net income of $103.3 million, or $1.66 per diluted share, up 23.9% from $83.4 million
Total assets were $14.9 billion at September 30, 2023, down from $15.5 billion at December 31, 2022; deposits fell to $11.9 billion from $12.7 billion
InterDigital reported third quarter 2023 revenue of $140.1 million, up 22%, mainly from catch-up revenues tied to two new patent license agreements, and net income attributable to the company of $47.9 million, up 116%. The company guided fourth quarter 2023 revenue to $102 million to $106 million and diluted EPS to $0.70 to $0.80, and raised its quarterly dividend to $0.40 per share from $0.35.
Q3 2023 total revenue was $140.1 million, up 22%, with catch-up revenues of $35.6 million versus $13.7 million a year earlier.
Q3 2023 net income attributable to InterDigital was $47.9 million, up 116%; diluted EPS was $1.72 versus $0.74.
Q4 2023 guidance: revenue of $102 million to $106 million and diluted EPS of $0.70 to $0.80, excluding any new agreements not yet signed.
Quarterly cash dividend increases to $0.40 per share from $0.35, beginning with the dividend paid in Q4 2023.
BrightSphere Investment Group Inc. (NYSE: BSIG) reported third-quarter 2023 results, with total revenue of $107.3 million, up 23.6% from a year earlier, and U.S. GAAP diluted EPS of $0.46 versus $0.42. Assets under management fell 2.5% in the quarter to $97.4 billion because of market declines and $(0.5) billion of net outflows. Note: the filing is from BrightSphere, which describes Acadian Asset Management as its sole operating business, not from Acadian Asset Management Inc. (AAMI) as the request stated.
Total revenue of $107.3 million in Q3 2023, up 23.6% from $86.8 million in Q3 2022
U.S. GAAP diluted EPS of $0.46 versus $0.42 a year earlier; ENI diluted EPS of $0.45 versus $0.30
AUM of $97.4 billion at September 30, 2023, down 2.5% from $99.9 billion at June 30, 2023, with net flows of $(0.5) billion
Board approved a $0.01 per share interim dividend payable December 28, 2023 to holders of record on December 15, 2023
Curtiss-Wright reported third-quarter 2023 sales of $724 million, up 15%, and GAAP diluted EPS of $2.51 versus $1.91 a year earlier. The company raised its full-year 2023 adjusted diluted EPS guidance to $9.00 to $9.20 from $8.90 to $9.15, and raised its sales growth and free cash flow ranges.
Q3 2023 sales of $724 million, up 15%; reported operating margin of 18.3%
GAAP diluted EPS of $2.51 vs $1.91; adjusted diluted EPS of $2.54, up 23%
2023 adjusted diluted EPS guidance raised to $9.00 to $9.20 from $8.90 to $9.15; sales growth guidance raised to 8% to 10%
Backlog of $2.9 billion, up 12% from December 31, 2022; conference call on November 2, 2023 at 10:00 a.m. ET
Strategic Education reported third-quarter 2023 results, with revenue up 8.7% to $285.9 million and diluted earnings per share of $0.77, compared with $0.25 a year earlier. Income from operations rose to $25.6 million from $7.8 million, though GAAP results include $3.3 million in restructuring costs. The company also declared a $0.60 per share quarterly dividend and will hold an Investor and Analyst Day on November 7, 2023.
Revenue rose 8.7% to $285.9 million from $263.1 million a year earlier.
Diluted EPS was $0.77 versus $0.25; adjusted diluted EPS, a non-GAAP measure, was $0.97 versus $0.33.
Net income was $18.5 million versus $6.1 million; restructuring costs were $3.3 million versus $0.6 million.
Quarterly dividend of $0.60 per share is payable December 4, 2023 to holders of record on November 27, 2023.
NMI Holdings, Inc. reported net income of $84.0 million, or $1.00 per diluted share, for the quarter ended September 30, 2023, up from $80.3 million ($0.95 per share) in the second quarter and $76.8 million ($0.90 per share) a year earlier. Total revenue rose to $148.2 million, and primary insurance-in-force reached $194.8 billion, which shows growth in both earnings and the insured portfolio for shareholders.
Net income $84.0 million, $1.00 diluted EPS, versus $80.3 million, $0.95 in Q2 2023 and $76.8 million, $0.90 in Q3 2022
Total revenue $148.2 million, versus $142.7 million in Q2 2023 and $130.6 million in Q3 2022
Primary insurance-in-force $194.8 billion at quarter end, versus $179.2 billion at September 30, 2022
Book value per share excluding net unrealized gains and losses $24.56, up 18% from $20.85 a year earlier
Airbnb reported third-quarter 2023 revenue of $3.4 billion, up 18% from a year earlier, and net income of $4.4 billion. Net income included a one-time, non-cash $2.8 billion income tax benefit, so adjusted net income of $1.6 billion, up from $1.2 billion, better reflects operations. For shareholders, the company guided fourth-quarter revenue to $2.13 billion to $2.17 billion, implying 12% to 14% growth, and said it repurchased $500 million of stock in the quarter.
Q3 revenue of $3.4 billion, up 18% year-over-year (14% excluding FX)
Q3 net income of $4.4 billion included a $2.8 billion one-time, non-cash tax benefit; adjusted net income was $1.6 billion versus $1.2 billion a year earlier
Adjusted EBITDA of $1.8 billion, up 26% year-over-year
Q4 2023 revenue outlook of $2.13 billion to $2.17 billion, implying 12% to 14% growth; company expects nights booked growth to moderate
TG Therapeutics reported results for the third quarter ended September 30, 2023, with total revenue of $165.8 million, of which $140.0 million was a one-time payment from Neuraxpharm. The company reported net income of $113.9 million, compared with a net loss of $35.8 million a year earlier, and said cash, cash equivalents and investment securities were $229.2 million at quarter end.
Q3 2023 total revenue of $165.8 million, including $140.0 million of license revenue tied to a one-time Neuraxpharm payment received in July 2023
BRIUMVI U.S. net sales of $25.1 million in Q3 2023, up from $0.1 million in Q3 2022
Q3 2023 net income of $113.9 million, or $0.80 per basic share, versus a net loss of $35.8 million in Q3 2022
Cash, cash equivalents and investment securities of $229.2 million as of September 30, 2023
Garmin reported third quarter 2023 revenue of $1.28 billion, up 12%, with operating income of $270 million, up 13%, and pro forma diluted EPS of $1.41, up 14%. The company also raised its full-year 2023 outlook to about $5.150 billion in revenue and $5.25 pro forma EPS, which matters to shareholders because it signals stronger expected earnings for the year.
Q3 2023 net sales were $1.28 billion, up 12%; GAAP diluted EPS was $1.34, up 23%
Q3 pro forma diluted EPS was $1.41, up 14%; fitness revenue rose 26% and auto OEM rose 59%
2023 guidance now calls for about $5.150 billion revenue and $5.25 pro forma EPS
Next dividend installment of $0.73 per share is payable March 29, 2024, with a record date of March 15, 2024
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.